Plain-English translation of NCT05779631 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a special type of MRI scan combined with a same-day biopsy can diagnose aggressive bladder cancer as well as—or better than—the current standard surgery. Researchers want to understand if this newer approach helps patients get diagnosed faster, start treatment sooner, and spend less money overall. The study will follow about 360 patients to compare how well each diagnostic method works.
Currently, doctors use a surgical procedure called TURBT as the standard way to diagnose muscle-invasive bladder cancer. However, researchers want to know if the advanced imaging approach might be safer, faster, or more cost-effective while giving equally reliable results.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups: either you'll receive an advanced MRI scan followed by a same-day biopsy procedure, or you'll receive the standard surgical procedure (TURBT). Researchers will then monitor your progress, track how quickly you move toward definitive treatment, and measure treatment outcomes over time. The study will also compare costs and survival between the two approaches.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Netherlands